Values and worries of ovarian cancer patients

Maria Pisu, Kelly M. Kenzik, Sun Hee Rim, Ellen M. Funkhouser, Kerri S. Bevis, Ronald D. Alvarez, Guilherme Cantuaria, Rodney P. Rocconi, Michelle Martin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction Older women with ovarian cancer (OC) are less likely to receive guideline concordant treatment. Differences in values and worries about treatment may explain why. Methods Women with OC in 2013–2015 were surveyed about values and worries at the time of initial treatment. Existing values (11 item, e.g., maintaining quality of life) and worries (12 items, e.g., treatment side effects) scales were adapted based on OC literature. Responses were very/somewhat/a little/not at all important or worried. Principal Component Analyses (PCA) identified groups of values and worries that best explained scales’ variation. We examined proportions reporting very/somewhat important/worried on ≥ 1 item in each component by age (older ≥ 65 years, younger < 65 years). Results Of 170 respondents, 42.3% were older. PCA components for values were: functional well-being (3 survey items, proportion of variance explained [PoVE] 26.3%), length of life and sexual functioning (3 items, PoVE 20.1%), attitudes (3 items, PoVE 14.2%), and not becoming a burden (2 items, PoVE 13.7%). PCA components for worries were: economic (4 items, PoVE 27.2%), uncertainty (6 items, PoVE 26.0%), and family impact (2 items, PoVE 16.3%). Older women were less likely to indicate very/somewhat worried to ≥ 1 item in the economic (51.4% vs 72.4%, p = 0.006), uncertainty (80.6% vs. 98.0%, p = 0.001), and family impact component (55.6% vs. 70.4%, p = 0.03). No other age differences were found. Conclusions While worry during OC treatment decision-making may differ across age groups, values do not. Research should assess how differences in worry might affect OC medical decision-making for older and younger women.

Original languageEnglish (US)
Pages (from-to)433-438
Number of pages6
JournalGynecologic oncology
Volume147
Issue number2
DOIs
StatePublished - Nov 1 2017

Fingerprint

Ovarian Neoplasms
Principal Component Analysis
Uncertainty
Economics
Therapeutics
Decision Making
Age Groups
Quality of Life
Guidelines
Research
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this

Pisu, M., Kenzik, K. M., Rim, S. H., Funkhouser, E. M., Bevis, K. S., Alvarez, R. D., ... Martin, M. (2017). Values and worries of ovarian cancer patients. Gynecologic oncology, 147(2), 433-438. https://doi.org/10.1016/j.ygyno.2017.08.028

Values and worries of ovarian cancer patients. / Pisu, Maria; Kenzik, Kelly M.; Rim, Sun Hee; Funkhouser, Ellen M.; Bevis, Kerri S.; Alvarez, Ronald D.; Cantuaria, Guilherme; Rocconi, Rodney P.; Martin, Michelle.

In: Gynecologic oncology, Vol. 147, No. 2, 01.11.2017, p. 433-438.

Research output: Contribution to journalArticle

Pisu, M, Kenzik, KM, Rim, SH, Funkhouser, EM, Bevis, KS, Alvarez, RD, Cantuaria, G, Rocconi, RP & Martin, M 2017, 'Values and worries of ovarian cancer patients', Gynecologic oncology, vol. 147, no. 2, pp. 433-438. https://doi.org/10.1016/j.ygyno.2017.08.028
Pisu M, Kenzik KM, Rim SH, Funkhouser EM, Bevis KS, Alvarez RD et al. Values and worries of ovarian cancer patients. Gynecologic oncology. 2017 Nov 1;147(2):433-438. https://doi.org/10.1016/j.ygyno.2017.08.028
Pisu, Maria ; Kenzik, Kelly M. ; Rim, Sun Hee ; Funkhouser, Ellen M. ; Bevis, Kerri S. ; Alvarez, Ronald D. ; Cantuaria, Guilherme ; Rocconi, Rodney P. ; Martin, Michelle. / Values and worries of ovarian cancer patients. In: Gynecologic oncology. 2017 ; Vol. 147, No. 2. pp. 433-438.
@article{0c2eb83f06ca431ea78e99fd707c9b8f,
title = "Values and worries of ovarian cancer patients",
abstract = "Introduction Older women with ovarian cancer (OC) are less likely to receive guideline concordant treatment. Differences in values and worries about treatment may explain why. Methods Women with OC in 2013–2015 were surveyed about values and worries at the time of initial treatment. Existing values (11 item, e.g., maintaining quality of life) and worries (12 items, e.g., treatment side effects) scales were adapted based on OC literature. Responses were very/somewhat/a little/not at all important or worried. Principal Component Analyses (PCA) identified groups of values and worries that best explained scales’ variation. We examined proportions reporting very/somewhat important/worried on ≥ 1 item in each component by age (older ≥ 65 years, younger < 65 years). Results Of 170 respondents, 42.3{\%} were older. PCA components for values were: functional well-being (3 survey items, proportion of variance explained [PoVE] 26.3{\%}), length of life and sexual functioning (3 items, PoVE 20.1{\%}), attitudes (3 items, PoVE 14.2{\%}), and not becoming a burden (2 items, PoVE 13.7{\%}). PCA components for worries were: economic (4 items, PoVE 27.2{\%}), uncertainty (6 items, PoVE 26.0{\%}), and family impact (2 items, PoVE 16.3{\%}). Older women were less likely to indicate very/somewhat worried to ≥ 1 item in the economic (51.4{\%} vs 72.4{\%}, p = 0.006), uncertainty (80.6{\%} vs. 98.0{\%}, p = 0.001), and family impact component (55.6{\%} vs. 70.4{\%}, p = 0.03). No other age differences were found. Conclusions While worry during OC treatment decision-making may differ across age groups, values do not. Research should assess how differences in worry might affect OC medical decision-making for older and younger women.",
author = "Maria Pisu and Kenzik, {Kelly M.} and Rim, {Sun Hee} and Funkhouser, {Ellen M.} and Bevis, {Kerri S.} and Alvarez, {Ronald D.} and Guilherme Cantuaria and Rocconi, {Rodney P.} and Michelle Martin",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.ygyno.2017.08.028",
language = "English (US)",
volume = "147",
pages = "433--438",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Values and worries of ovarian cancer patients

AU - Pisu, Maria

AU - Kenzik, Kelly M.

AU - Rim, Sun Hee

AU - Funkhouser, Ellen M.

AU - Bevis, Kerri S.

AU - Alvarez, Ronald D.

AU - Cantuaria, Guilherme

AU - Rocconi, Rodney P.

AU - Martin, Michelle

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Introduction Older women with ovarian cancer (OC) are less likely to receive guideline concordant treatment. Differences in values and worries about treatment may explain why. Methods Women with OC in 2013–2015 were surveyed about values and worries at the time of initial treatment. Existing values (11 item, e.g., maintaining quality of life) and worries (12 items, e.g., treatment side effects) scales were adapted based on OC literature. Responses were very/somewhat/a little/not at all important or worried. Principal Component Analyses (PCA) identified groups of values and worries that best explained scales’ variation. We examined proportions reporting very/somewhat important/worried on ≥ 1 item in each component by age (older ≥ 65 years, younger < 65 years). Results Of 170 respondents, 42.3% were older. PCA components for values were: functional well-being (3 survey items, proportion of variance explained [PoVE] 26.3%), length of life and sexual functioning (3 items, PoVE 20.1%), attitudes (3 items, PoVE 14.2%), and not becoming a burden (2 items, PoVE 13.7%). PCA components for worries were: economic (4 items, PoVE 27.2%), uncertainty (6 items, PoVE 26.0%), and family impact (2 items, PoVE 16.3%). Older women were less likely to indicate very/somewhat worried to ≥ 1 item in the economic (51.4% vs 72.4%, p = 0.006), uncertainty (80.6% vs. 98.0%, p = 0.001), and family impact component (55.6% vs. 70.4%, p = 0.03). No other age differences were found. Conclusions While worry during OC treatment decision-making may differ across age groups, values do not. Research should assess how differences in worry might affect OC medical decision-making for older and younger women.

AB - Introduction Older women with ovarian cancer (OC) are less likely to receive guideline concordant treatment. Differences in values and worries about treatment may explain why. Methods Women with OC in 2013–2015 were surveyed about values and worries at the time of initial treatment. Existing values (11 item, e.g., maintaining quality of life) and worries (12 items, e.g., treatment side effects) scales were adapted based on OC literature. Responses were very/somewhat/a little/not at all important or worried. Principal Component Analyses (PCA) identified groups of values and worries that best explained scales’ variation. We examined proportions reporting very/somewhat important/worried on ≥ 1 item in each component by age (older ≥ 65 years, younger < 65 years). Results Of 170 respondents, 42.3% were older. PCA components for values were: functional well-being (3 survey items, proportion of variance explained [PoVE] 26.3%), length of life and sexual functioning (3 items, PoVE 20.1%), attitudes (3 items, PoVE 14.2%), and not becoming a burden (2 items, PoVE 13.7%). PCA components for worries were: economic (4 items, PoVE 27.2%), uncertainty (6 items, PoVE 26.0%), and family impact (2 items, PoVE 16.3%). Older women were less likely to indicate very/somewhat worried to ≥ 1 item in the economic (51.4% vs 72.4%, p = 0.006), uncertainty (80.6% vs. 98.0%, p = 0.001), and family impact component (55.6% vs. 70.4%, p = 0.03). No other age differences were found. Conclusions While worry during OC treatment decision-making may differ across age groups, values do not. Research should assess how differences in worry might affect OC medical decision-making for older and younger women.

UR - http://www.scopus.com/inward/record.url?scp=85030853021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030853021&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2017.08.028

DO - 10.1016/j.ygyno.2017.08.028

M3 - Article

VL - 147

SP - 433

EP - 438

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -